← board
VICP
distress 5/10 · elevated risk$1.460%today-18% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.7 yrs
Shares 1y
+85%
Price & events
-2.7% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
+0.0%
1M
+0.0%
3M
-2.7%
6M
-17.5%
1Y
-79.1%
2Y
+1459900.1%
5Y
-2.7%
All
Overview
- Market Cap
- $47.26M
- Volume
- 0
- 52 Week Range
- $0.15 – $1.77
- Total Shares
- 32.37M
- Float Shares
- 18.41M
- % Held by Insiders
- 18.75%
- % Held by Institutions
- 0.00%
- Beta
- 405483.80
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 32,371,299 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.